Jiangchao Wu

Zhejiang Provincial Key Laboratory Of Pancreatic Disease
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation.

Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 30, 2025

Tumor-associated CD19+ macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma.

Tumor-associated CD19+ macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma.

Journal: Nature communications

Published: March 22, 2025

GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma.

GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma.

Journal: Nature

Published: February 12, 2025

A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer.

A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer.

Journal: Oncogene

Published: January 24, 2025

Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomas.

Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomas.

Journal: Translational oncology

Published: March 29, 2024

Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.

Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.

Journal: Cancer letters

Published: November 14, 2023

IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling.

IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling.

Journal: Cell reports

Published: September 01, 2023

Low-Pass Genomic Sequencing Reveals Novel Subtypes of Pancreatic Cystic Neoplasms.

Low-Pass Genomic Sequencing Reveals Novel Subtypes of Pancreatic Cystic Neoplasms.

Journal: Annals of surgical oncology

Published: March 10, 2023

Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability.

Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability.

Journal: Journal for immunotherapy of cancer

Published: February 08, 2023

Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation.

Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation.

Journal: BMC cancer

Published: September 21, 2022

Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study.

Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study.

Journal: Gut

Published: March 31, 2022

Recent Advancements of Nanotechnology-Based Strategies for Overcoming Tumor Microenvironment Hypoxia.

Recent Advancements of Nanotechnology-Based Strategies for Overcoming Tumor Microenvironment Hypoxia.

Journal: Frontiers in bioscience (Landmark edition)

Published: February 08, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026